HealthDay speaks with Dr. Nicole Brady, CMO of United Healthcare, about the surprising results of their new Behavioral Health Report on college students and recent graduates.

ADHD patients who begin drug treatment within 3 months of diagnosis have significantly lower odds of suicidal ideation, substance misuse, car accidents and criminality, according to a new study.

In a new study, researchers found no association between treatment with GLP-1 Receptor Agonists like Ozempic and Wegovy and increased risk of adverse psychiatric events.

Researchers find no link between semaglutide, the main ingredient in Ozempic and Wegovy, and depression, suicidal thoughts or behaviors in patients with no prior history of the conditions.